Dionyssios N Sgouras

Title: Dionyssios N Sgouras: Innovator in Genetic Research

Introduction

Dionyssios N Sgouras is a notable inventor based in Athens, Greece. He has made significant contributions to the field of genetic research, particularly in the study of tumorigenicity. With a total of 2 patents, his work has implications for cancer treatment and understanding genetic factors in tumor development.

Latest Patents

Sgouras's latest patents focus on the ETS2 repressor factor (ERF). The first patent relates to the ERF gene and the products encoded by this gene. It includes DNA sequences encoding ERF and AERF, polypeptides encoded by such DNA sequences, and ERF chimeric molecules. The methods described in this patent aim to reduce tumorigenicity in tumor cells. The second patent also pertains to the ERF genetic locus and its products, emphasizing similar aspects of DNA sequences and their applications in cancer research.

Career Highlights

Throughout his career, Sgouras has worked with prominent organizations, including the United States of America as represented by the Department of Health and the National Institutes of Health. His research has contributed to advancements in understanding genetic factors related to cancer.

Collaborations

Sgouras has collaborated with notable individuals in his field, including George J Mavrothalassitis and Donald G Blair. These collaborations have furthered his research and expanded the impact of his inventions.

Conclusion

Dionyssios N Sgouras is a distinguished inventor whose work in genetic research has the potential to influence cancer treatment significantly. His patents on the ETS2 repressor factor highlight his commitment to advancing scientific knowledge and improving health outcomes.